Chief Financial Officer of Aytu BioPharma Receives Lucrative Stock Options Amid Market Challenges
On August 16, 2023, an intriguing revelation emerged from the U.S. Securities and Exchange Commission, shedding light on the remarkable ...
Tag: AYTU
Initiating Coverage on Aytu BioPharma Analyst Predicts Growth and Potential
On August 9, 2023, Maxim Group analyst Naz Rahman made a significant move by initiating coverage on Aytu BioPharma (NASDAQ:AYTU) ...
Aytu BioPharma Submits Prior Approval Supplement for Transfer of Cotempla XRODTs Manufacturing Site
On July 10, 2023, Aytu BioPharma took a significant step by submitting a Prior Approval Supplement (PAS) for the transfer ...
Nantahala Capital Management LLC Increases Ownership in Aytu BioPharma A Closer Look at the SEC Filing
As of May 26, 2023, Nantahala Capital Management, LLC has boosted its ownership in Aytu BioPharma by 7.2%, as per ...
Aytu BioPharma to Unveil Q3 Fiscal 2023 Financial Results Analysts Estimate EPS of 063
On May 10, 2023, Aytu BioPharma (NASDAQ:AYTU) is set to unveil its third-quarter fiscal 2023 financial results at 4:30 pm ...